InvestorsHub Logo
Followers 40
Posts 5339
Boards Moderated 0
Alias Born 11/15/2013

Re: None

Friday, 07/14/2017 10:20:06 AM

Friday, July 14, 2017 10:20:06 AM

Post# of 288
Aironite Significantly Lowered Pulmonary Artery Pressures and Significantly Increased Pulmonary Arterial Compliance.

"These additional results build upon prior interim data published last year in the Journal of Clinical Investigation, and demonstrate that Aironite can significantly improve cardiopulmonary hemodynamics in HFpEF as well as Group 3 PH patients, both clinical conditions which are inadequately treated by currently approved medicinal treatments," stated Taneli Jouhikainen, M.D., Ph.D., Chief Operating Officer of Savara.

This could be huge folks.

https://finance.yahoo.com/news/positive-interim-results-aironite-phase-120000315.html


My posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SVRA News